Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Amelia Melo, Jose Manuel Carrascosa & Tiago Torres. (2022) Baricitinib for the treatment of atopic dermatitis. Journal of Dermatological Treatment 33:5, pages 2404-2413.
Read now
Read now
Francisco A. Kerdel, Zoe D. Draelos, Stephen K. Tyring, Tina Lin & Radhakrishnan Pillai. (2019) A phase 2, multicenter, double-blind, randomized, vehicle-controlled clinical study to compare the safety and efficacy of a halobetasol propionate 0.01% lotion and halobetasol propionate 0.05% cream in the treatment of plaque psoriasis. Journal of Dermatological Treatment 30:4, pages 333-339.
Read now
Read now
Seung Yeon Song, Sun-Young Jung & EunYoung Kim. (2019) Steroid phobia among general users of topical steroids: a cross-sectional nationwide survey. Journal of Dermatological Treatment 30:3, pages 245-250.
Read now
Read now
Paul Yamauchi. (2017) DFD-01: a novel topical formulation of betamethasone dipropionate for the treatment of extensive psoriasis. Expert Review of Clinical Immunology 13:2, pages 85-91.
Read now
Read now
John Koo, Stephen Tyring, William P. Werschler, Suzanne Bruce, Martin Olesen, John Villumsen & Jerry Bagel. (2016) Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris – A randomized phase II study. Journal of Dermatological Treatment 27:2, pages 120-127.
Read now
Read now
Articles from other publishers (30)
Astrid Herzum, Corrado Occella, Lodovica Gariazzo, Carlotta Pastorino & Gianmaria Viglizzo. (2023) Corticophobia among Parents of Children with Atopic Dermatitis: Assessing Major and Minor Risk Factors for High TOPICOP Scores. Journal of Clinical Medicine 12:21, pages 6813.
Crossref
Crossref
Sultan Daghafak Alenazi. (2023) Atopic dermatitis: a brief review of recent advances in management. Dermatology Reports.
Crossref
Crossref
Paula Finnegan, Michelle Murphy & Cathal O’Connor. (2023) #corticophobia: a review on online misinformation related to topical steroids. Clinical and Experimental Dermatology 48:2, pages 112-115.
Crossref
Crossref
Stefan Eirefelt, Martin Stahlhut, Naila Svitacheva, Martin A. Carnerup, Joel Mauricio Correa Da Rosa, David Adrian Ewald, Troels T. Marstrand, Mikkel Krogh-Madsen, Georg Dünstl, Kevin Neil Dack, Anna Ollerstam & Hanne Norsgaard. (2022) Characterization of a novel non-steroidal glucocorticoid receptor agonist optimized for topical treatment. Scientific Reports 12:1.
Crossref
Crossref
Enes Hajdarbegovic & Anneke de Vos. (2021) Noem corticosteroïdenzalf geen ‘hormoonzalf’. Huisarts en wetenschap 65:1, pages 44-47.
Crossref
Crossref
Jenny G. Chung, Harriet Cheng, Michael Croxson, Karen Agnew, Jane Alsweiler & Steven Lamb. (2021) Topical corticosteroid wet wrap treatment and adrenal suppression: An Auckland perspective. JAAD International 5, pages 66-68.
Crossref
Crossref
Matthew Ladda & Philip Doiron. (2021) Addressing topical corticosteroid phobia in atopic dermatitis: The role of the pharmacist. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada 154:2, pages 71-73.
Crossref
Crossref
Y. Tada, L. Iversen & J. Koo. (2021) Early efficacy and safety data with fixed‐dose combination calcipotriol/betamethasone dipropionate foam attributed to mechanism of absorption and steroid potency. Journal of the European Academy of Dermatology and Venereology 35:S1, pages 5-9.
Crossref
Crossref
Linda Stein Gold, Javier Alonso-Llamazares, Jean-Philippe Lacour, Richard B. Warren, Stephen K. Tyring, Leon Kircik, Paul Yamauchi & Mark Lebwohl. (2020) PSO-LONG: Design of a Novel, 12-Month Clinical Trial of Topical, Proactive Maintenance with Twice-Weekly Cal/BD Foam in Psoriasis. Advances in Therapy 37:11, pages 4730-4753.
Crossref
Crossref
Kristine J. Kucera & Judi Elizabeth Miller. (2020) Treatment of Palmoplantar Pustulosis Using Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% Lotion: A Case Report. Journal of Psoriasis and Psoriatic Arthritis 5:4, pages 164-167.
Crossref
Crossref
Vignesh Ramachandran, Brooke Bertus, Arjun M. Bashyam & Steven R. Feldman. (2020) Treating Psoriasis With Halobetasol Propionate and Tazarotene Combination: A Review of Phase II and III Clinical Trials. Annals of Pharmacotherapy 54:9, pages 872-878.
Crossref
Crossref
Sayaka Kuwatsuka, Yuta Koike, Yumi Hanatani, Naoya Murayama, Akira Iwanaga & Hiroyuki Murota. (2020) Bright side of biologics uncovered the dark side of long‐term topical steroids: A psoriatic patient treated with biologics developed severe adrenal crisis. The Journal of Dermatology 47:8.
Crossref
Crossref
Sinéad M Langan, Alan D Irvine & Stephan Weidinger. (2020) Atopic dermatitis. The Lancet 396:10247, pages 345-360.
Crossref
Crossref
Helen Simpson, Jeremy Tomlinson, John Wass, John Dean & Wiebke Arlt. (2020) Guidance for the prevention and emergency management of adult patients with adrenal insufficiency. Clinical Medicine 20:4, pages 371-378.
Crossref
Crossref
Hao Chen, Jianfang Sun, Haizhen Yang, Qiuning Sun, Jianzhong Zhang, Jun Gu, Hai Wen, Ming Li, Xiaoming Liu, Huilan Yang & Donghua Lou. (2020) Fixed combination of tazarotene and betamethasone dipropionate for treatment of psoriasis vulgaris: The result of a phase 3, multicenter, randomized controlled trial. The Journal of Dermatology 47:7, pages 728-734.
Crossref
Crossref
T. Woodcock, P. Barker, S. Daniel, S. Fletcher, J. A. H. Wass, J. W. Tomlinson, U. Misra, M. Dattani, W. Arlt & A. Vercueil. (2020) Guidelines for the management of glucocorticoids during the peri‐operative period for patients with adrenal insufficiency. Anaesthesia 75:5, pages 654-663.
Crossref
Crossref
Juan Bertholle-Gil, Apolonia Gil-Palmer & Joana Nicolau-Ramis. (2020) Insuficiencia suprarrenal secundaria a clobetasol tópico. Medicina Clínica 154:8, pages 324-325.
Crossref
Crossref
Juan Bertholle-Gil, Apolonia Gil-Palmer & Joana Nicolau-Ramis. (2020) Adrenal insufficiency secondary to topic clobetasol. Medicina Clínica (English Edition) 154:8, pages 324-325.
Crossref
Crossref
Anna B. Fishbein, Kelly Mueller, Jennifer Lor, Patricia Smith, Amy S. Paller & Aaron Kaat. (2019) Systematic Review and Meta-analysis Comparing Topical Corticosteroids With Vehicle/Moisturizer in Childhood Atopic Dermatitis. Journal of Pediatric Nursing 47, pages 36-43.
Crossref
Crossref
Mark G. Lebwohl, Jeffrey L. Sugarman, Linda Stein Gold, David M. Pariser, Tina Lin, Radhakrishnan Pillai, Gina Martin, Susan Harris & Robert Israel. (2019) Long-term safety results from a phase 3 open-label study of a fixed combination halobetasol propionate 0.01% and tazarotene 0.045% lotion in moderate-to-severe plaque psoriasis. Journal of the American Academy of Dermatology 80:1, pages 282-285.
Crossref
Crossref
Linda Stein Gold, Mark G. Lebwohl, Jeffrey L. Sugarman, David M. Pariser, Tina Lin, Gina Martin, Radhakrishnan Pillai, Robert Israel & Tage Ramakrishna. (2018) Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trials. Journal of the American Academy of Dermatology 79:2, pages 287-293.
Crossref
Crossref
Ji Hyun Lee & Young Min Park. (2018) Proper use of topical corticosteroids. Journal of the Korean Medical Association 61:10, pages 632.
Crossref
Crossref
Alexandra Ahmet, Vincent Brienza, Audrey Tran, Julie Lemieux, Mary Aglipay, Nick Barrowman, Ciaran Duffy, Johannes Roth & Roman Jurencak. (2017) Frequency and Duration of Adrenal Suppression Following Glucocorticoid Therapy in Children With Rheumatic Diseases. Arthritis Care & Research 69:8, pages 1224-1230.
Crossref
Crossref
C. Queille‐Roussel, B. Bang, F. Clonier & J.‐P. Lacour. (2016) Enhanced vasoconstrictor potency of the fixed combination calcipotriol plus betamethasone dipropionate in an innovative aerosol foam formulation vs. other corticosteroid psoriasis treatments. Journal of the European Academy of Dermatology and Venereology 30:11, pages 1951-1956.
Crossref
Crossref
Kirsten Rønholt Stausholm, Eva Spaun & Uffe Koppelhus. (2016) A Case of Therapy-Resistant Folliculitis due to Adrenal Insufficiency. Case Reports in Dermatology 8:3, pages 267-271.
Crossref
Crossref
Manfred Bodenlenz, Christian Dragatin, Lisa Liebenberger, Bernd Tschapeller, Beate Boulgaropoulos, Thomas Augustin, Reingard Raml, Christina Gatschelhofer, Nathalie Wagner, Khaled Benkali, Francois Rony, Thomas Pieber & Frank Sinner. (2016) Kinetics of Clobetasol-17-Propionate in Psoriatic Lesional and Non-Lesional Skin Assessed by Dermal Open Flow Microperfusion with Time and Space Resolution. Pharmaceutical Research 33:9, pages 2229-2238.
Crossref
Crossref
Jason E. Hawkes & Kristina Callis Duffin. 2016. Psoriatic Arthritis and Psoriasis. Psoriatic Arthritis and Psoriasis
253
266
.
Melissa Danesh, Catherine Nguyen, Kourosh Beroukhim & John Koo. (2015) Evolution of Topical Therapy in the Treatment of Psoriasis: A Review. Journal of Psoriasis and Psoriatic Arthritis 1:1a, pages 2-13.
Crossref
Crossref
Emma Mooney, Marius Rademaker, Rebecca Dailey, Ben S Daniel, Catherine Drummond, Gayle Fischer, Rachael Foster, Claire Grills, Anne Halbert, Sarah Hill, Emma King, Elizabeth Leins, Vanessa Morgan, Roderic J Phillips, John Relic, Michelle Rodrigues, Laura Scardamaglia, Saxon Smith, John Su, Orli Wargon & David Orchard. (2015) Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement. Australasian Journal of Dermatology 56:4, pages 241-251.
Crossref
Crossref
Christian Vestergaard & Mette Deleuran. (2014) Advances in the Diagnosis and Therapeutic Management of Atopic Dermatitis. Drugs 74:7, pages 757-769.
Crossref
Crossref